Literature DB >> 15582545

Umbilical cord blood stem cells.

Ian Rogers1, Robert F Casper.   

Abstract

The umbilical cord contains a rich source of haematopoietic stem cells that can be used to reconstitute the blood system and can easily be extracted and cryopreserved, thus allowing for the establishment of HLA-typed stem cell banks. Recently, it has been demonstrated that umbilical cord stem cells have the potential to give rise to non-haematopoietic cells, such as bone, neural and endothelial cells. It is not clear whether these multipotential cells are mesenchymal-like cells or blood cells. Currently, the number of these specialized cells capable of undergoing the differentiation process into non-haematopoietic cells is low and remains a block to the clinical development of umbilical cord stem cells for non-haematopoietic cell therapy. Further research will allow us to overcome these hurdles. This expanded potential for umbilical cord stem cells might replace embryonic stem cells and other fetal cells for some cell and tissue therapies.

Mesh:

Year:  2004        PMID: 15582545     DOI: 10.1016/j.bpobgyn.2004.06.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  37 in total

1.  Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa.

Authors:  Madelein Meissner-Roloff; Wendy Young; Isabella Rangaka; Hennie Lombaard; Ames Dhai; Norma Tsotsi; Michael S Pepper
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  NHS maternity units should not encourage commercial banking of umbilical cord blood.

Authors:  Leroy C Edozien
Journal:  BMJ       Date:  2006-10-14

3.  Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Authors:  Dongjie Li; Jiake Chai; Chuanan Shen; Yanfu Han; Tianjun Sun
Journal:  Cytotechnology       Date:  2014-06-21       Impact factor: 2.058

Review 4.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 5.  Diabetes-associated macrovascular complications: cell-based therapy a new tool?

Authors:  Maddalena Gili; Alberto Orsello; Sara Gallo; Maria Felice Brizzi
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 6.  Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options.

Authors:  Courtney A McDonald; Michael C Fahey; Graham Jenkin; Suzanne L Miller
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

7.  Increased in vitro migration of human umbilical cord mesenchymal stem cells toward acellular foreskin treated with bacterial derivatives of monophosphoryl lipid A or supernatant of Lactobacillus acidophilus.

Authors:  Ali Shojaeian; Ameneh Mehri-Ghahfarrokhi; Mehdi Banitalebi-Dehkordi
Journal:  Hum Cell       Date:  2019-12-06       Impact factor: 4.174

8.  Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs.

Authors:  Ji Hey Lim; Ye Eun Byeon; Hak Hyun Ryu; Yun Hyeok Jeong; Young Won Lee; Wan Hee Kim; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

9.  Generation of human/rat xenograft animal model for the study of human donor stem cell behaviors in vivo.

Authors:  Yan Sun; Dong Xiao; Xing-Hua Pan; Ruo-Shuang Zhang; Guang-Hui Cui; Xi-Gu Chen
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

10.  Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs.

Authors:  Byung Jun Jang; Ye Eun Byeon; Ji Hey Lim; Hak Hyun Ryu; Wan Hee Kim; Yoshihisa Koyama; Masanori Kikuchi; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.